Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Processa Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered | Proposed | Proposed Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Common Stock, par value $0.0001 per share(2) | Rule 457(o) | $ | 7,000,000(3) | $ | 0.00014760 | $ | 1,033.20 | ||||||||||||||||
| Equity | Common Warrants(4) | Rule 457(g) | - | |||||||||||||||||||||
| Equity | Pre-Funded Warrants(4) | Rule 457(g) | - | |||||||||||||||||||||
| Equity | Placement Agent Warrants(4) (5) | Other | - | |||||||||||||||||||||
| Equity | Common stock issuable upon exercise of the Common Warrant(2) | Rule 457(o) | $ | 7,000,000 | $ | 0.00014760 | $ | 1,033.20 | ||||||||||||||||
| Equity | Common Stock issuable upon exercise of the Pre-Funded Warrants(2) | Rule 457(o) | (3 | ) | ||||||||||||||||||||
| Equity | Common Stock issuable upon exercise of the Placement Agent Warrants(2) | Rule 457(o) | $ | 350,000 | $ | 0.00014760 | $ | 51.66 | ||||||||||||||||
| Total Offering Amounts | $ | 14,350,000 | $ | 2,118.06 | ||||||||||||||||||||
| Total Fees Previously Paid | ||||||||||||||||||||||||
| Total Fee Offsets | ||||||||||||||||||||||||
| Net Fee Due | $ | 2,118.06 | ||||||||||||||||||||||
| (1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
| (2) | Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (3) | The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants sold in the offering, and, as such, the proposed maximum aggregate offering price of the common stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $7,000,000. |
| (4) | Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants. |
| (5) | Represents warrants issuable to the placement agent, or its designees, to purchase a number of shares of common stock equal to 4.0% of the shares of common stock sold in this offering (including the shares of common stock issuable upon the exercise of the Pre-Funded Warrants but not including shares of common stock sold to current directors and officers of the Company), at an exercise price equal to 125% of the public offering price per share and accompanying warrant. |
